This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Evening networking is a punishment for working parents – Mark Debono
The issue, he argues, lies in how professional life continues to be structured as if parenting does not exist.
ITS appoints Simon Caurana as Director of Centre of Contemporary Tourism
This role requires him to serve as the founding strategic leader of the newly established centre.
Thomas Agius Ferrante appointed CEO of Xara Collection
Thomas Agius Ferrante will focused on strengthening The Xara Collection as one of Malta’s most known hospitality companies.
Andrew Hogg is The Brewhouse Malta’s new Business Development Manager
Andrew Hogg is also Executive Director at The BrewHouse Malta.
